James J-D Hsieh Selected Research

cathepsin Q

1/2009

The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James J-D Hsieh Research Topics

Disease

7	Leukemia 12/2011 - 01/2003
6	Neoplasms (Cancer) 03/2013 - 09/2006
2	Oncogene Addiction 03/2013 - 07/2010
1	Lung Neoplasms (Lung Cancer) 03/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Breast Neoplasms (Breast Cancer) 02/2012
1	Brain Neoplasms (Brain Tumor) 02/2012
1	Hypersensitivity (Allergy) 08/2009
1	Necrosis 01/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2003
3	Threonine (L-Threonine)FDA Link 02/2012 - 09/2006
3	Peptide Hydrolases (Proteases)FDA Link 02/2012 - 09/2009
2	Histones (Histone)IBA 01/2013 - 10/2007
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 12/2011
2	EndopeptidasesIBA 02/2012 - 09/2006
2	Nuclear Proteins (Protein, Nuclear)IBA 10/2003 - 01/2003
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	human ERBB2 proteinIBA 03/2013
1	Tyrosine Kinase InhibitorsIBA 03/2013
1	CaspasesIBA 03/2013
1	CytokinesIBA 01/2013
1	CXC ChemokinesIBA 01/2013
1	Polycomb Repressive Complex 2IBA 01/2013
1	NSC48300IBA 02/2012
1	Protein MethyltransferasesIBA 12/2011
1	ABT-737IBA 07/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2009
1	cathepsin QIBA 01/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009

Therapy/Procedure

3	Therapeutics 02/2012 - 09/2006